EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Autoinflammatory syndromes of STING and TREX1 dysfunction

Debby J Park, Kate M Jones, Jessica B Anderson, Amanda V Finck, Jonathan J Miner

Journal of Clinical Investigation · 01.06.2026 · 136 (11)

DOI: 10.1172/jci204549 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Investigation, online erschienen am 01.06.2026. Verfasst von Debby J Park und 4 weiteren Autor:innen. Beteiligte Einrichtung: RVCL Research Center, Department of Medicine. Hauptthemen laut MEDLINE: Exodeoxyribonucleases, Phosphoproteins, Membrane Proteins, Leukoencephalopathies. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 177 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breakthroughs in rare genetic disease research elucidate the relationships among cytosolic DNA sensing, genome instability, and autoimmune disease phenotypes. Cytosolic self-DNA is a potent trigger of innate immunity, activating the DNA sensor cyclic GMP-AMP synthase (cGAS) and its downstream effector stimulator of interferon genes (STING). This pathway is negatively regulated by the DNA-degrading enzyme three-prime repair exonuclease 1 (TREX1); loss-of-function TREX1 variants lead to accumulation of cytosolic DNA, resulting in STING-mediated autoinflammation. Similarly, STING gain-of-function mutations cause STING-associated vasculopathy with onset in infancy, another disease characterized by multi-organ damage, disability, and premature death. The TREX1-cGAS-STING pathway has also been implicated in regulation of genome stability. Indeed, DNA damage lies at the heart of a separate TREX1-mediated disease, known as retinal vasculopathy with cerebral leukoencephalopathy, where the aberrant nuclear activity of mislocalized TREX1 damages genomic DNA, resulting in multi-organ degeneration syndrome with features of autoimmunity. Thus, monogenic autoimmune diseases and DNA damage syndromes sometimes overlap clinically, and the study of these diseases has created pathways for developing first-in-class small molecule therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExodeoxyribonucleasesPhosphoproteinsMembrane ProteinsLeukoencephalopathiesAutoimmune DiseasesHumansSTING ProteinAnimalscGAS-STING Signaling PathwaySignal TransductionDNA DamageSyndromeCyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase

Substanzen

Exodeoxyribonucleasesthree prime repair exonuclease 1STING ProteinPhosphoproteinsSTING1 protein, humanMembrane ProteinsCyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase

Autor:innen und Institutionen

  • RVCL Research Center, Department of Medicine.
  • Department of Microbiology.
  • Institute for Immunology and Immune Health; and.
  • Colton Center for Autoimmunity, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Förderung

  • NIAID NIH HHS
  • NINDS NIH HHS

Zitieren

APA

Park, D. J., Jones, K. M., Anderson, J. B., Finck, A. V., & Miner, J. J. (2026). Autoinflammatory syndromes of STING and TREX1 dysfunction. Journal of Clinical Investigation, 136(11). https://doi.org/10.1172/jci204549

Vancouver

Park DJ, Jones KM, Anderson JB, Finck AV, Miner JJ. Autoinflammatory syndromes of STING and TREX1 dysfunction. Journal of Clinical Investigation. 2026;136(11). doi:10.1172/jci204549

BibTeX
@article{Park2026,
  author = {Park, Debby J and Jones, Kate M and Anderson, Jessica B and Finck, Amanda V and Miner, Jonathan J},
  title = {Autoinflammatory syndromes of STING and TREX1 dysfunction},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  volume = {136},
  number = {11},
  doi = {10.1172/jci204549}
}
Kostenlos starten →